ESPOSITO, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 7.383
EU - Europa 6.462
AS - Asia 1.488
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
AF - Africa 3
Totale 15.352
Nazione #
US - Stati Uniti d'America 7.320
IE - Irlanda 2.181
SE - Svezia 1.774
CN - Cina 1.279
IT - Italia 839
UA - Ucraina 362
PL - Polonia 322
DE - Germania 282
FI - Finlandia 257
GB - Regno Unito 220
IN - India 115
BE - Belgio 74
CA - Canada 62
AT - Austria 56
VN - Vietnam 48
FR - Francia 32
RU - Federazione Russa 22
NL - Olanda 19
IR - Iran 10
TW - Taiwan 10
EU - Europa 5
AU - Australia 4
CL - Cile 4
JP - Giappone 4
CH - Svizzera 3
HK - Hong Kong 3
HU - Ungheria 3
IQ - Iraq 3
JO - Giordania 3
SG - Singapore 3
BG - Bulgaria 2
DK - Danimarca 2
ES - Italia 2
KR - Corea 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
AR - Argentina 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EE - Estonia 1
KG - Kirghizistan 1
MA - Marocco 1
MK - Macedonia 1
MM - Myanmar 1
MT - Malta 1
MX - Messico 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
Totale 15.352
Città #
Dublin 2.181
Chandler 1.614
Nyköping 1.215
Jacksonville 824
Beijing 502
Ashburn 435
Princeton 404
Dearborn 348
Warsaw 320
Medford 312
Messina 280
Des Moines 258
Cambridge 250
Ann Arbor 231
Boardman 154
Lancaster 128
New York 126
Shenyang 100
Jinan 98
Wilmington 88
Brussels 72
Houston 71
Nanjing 68
San Mateo 64
Woodbridge 60
Pune 59
Tianjin 56
Vienna 56
Ottawa 55
Cologne 52
Dong Ket 48
Hebei 48
Ningbo 45
Zhengzhou 45
Hyderabad 44
Haikou 41
Catania 40
Guangzhou 35
Nanchang 32
Falls Church 30
Rome 30
Francofonte 27
Taizhou 27
Washington 27
Hangzhou 26
Milan 25
Fuzhou 23
Norwalk 23
Tappahannock 23
Seattle 22
Helsinki 18
Piazza Armerina 18
Jiaxing 17
Lanzhou 15
Los Angeles 14
Marsala 14
Changsha 13
Cusano Milanino 13
Catanzaro 10
Pace 10
Reutlingen 10
St Louis 10
College Station 9
Fairfield 9
Palermo 9
Bremen 8
Sannicandro Di Bari 8
Taiyuan 8
Florence 7
London 7
Napoli 7
Shenzhen 7
Turin 7
Auburn Hills 6
Kunming 6
Lappeenranta 6
Misterbianco 6
Naples 6
Brescia 5
Chicago 5
Hefei 5
Mountain View 5
Redwood City 5
Saint Petersburg 5
Yuanlin 5
Acireale 4
Fort Worth 4
Kemerovo 4
Noto 4
Ragusa 4
Santa Maria del Cedro 4
Spilamberto 4
Acate 3
Amman 3
Ardabil 3
Biella 3
Bitonto 3
Canicattini Bagni 3
Caserta 3
Corigliano Calabro 3
Totale 11.507
Nome #
Celenterati Cnidari come modello per lo studio di tossicità da metalli pesanti. 110
Ethyl-piruvate reduces the developments of zymosine-induced generalized inflammatory in mice 94
Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury 93
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 93
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2 93
Role of melatonin supplementation in neurodegenerative disorders. 89
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 89
Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. 89
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 84
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury 83
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats 83
Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury. 81
Dimethyl fumarate reduces inflammatory responses in experimental colitis 81
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 78
Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis 76
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation 76
The anti-inflammatory and antioxidant potential of pistachios (Pistacia vera L.) in vitro and in vivo 76
Multiple mechanisms of dimethyl fumarate in amyloid β-induced neurotoxicity in human neuronal cells 75
Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury 74
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 74
Anti-inflammatory and Antioxidant Effects of Flavonoid-Rich Fraction of Bergamot Juice (BJe) in a Mouse Model of Intestinal Ischemia/Reperfusion Injury 73
Correction to: Potential eye drop based on a calix[4]arene nanoassembly for curcumin delivery: Enhanced drug solubility, stability, and anti-inflammatory effect (Molecular Pharmaceutics (2017) 14:5 (1610-1622) DOI: 10.1021/acs.molpharmaceut.6b01066) 73
Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease 71
Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-alpha 69
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 69
Influence of coagulase-negative staphylococci as potential probiotics on Dry Eye 69
Glycogen synthase kinase 3 beta inhibition reduces the development of nonseptic shock induced by zymosan in mice 68
Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis. 68
KU0063794, a Dual mTORC1 and mTORC2 Inhibitor, Reduces Neural Tissue Damage and Locomotor Impairment After Spinal Cord Injury in Mice 68
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man 67
2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation 66
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 65
Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats. 64
N-palmitoylethanolamine administration ameliorates the clinical manifestation and progression of experimental autoimmune encephalomyelitis in rodents 64
Protective effects of xyloglucan in association with the polysaccharide gelose in an experimental model of gastroenteritis and urinary tract infections 64
Fumaric acid esters attenuate degeneration and promote functional recovery following Parkinson’s disease 64
The anti-inflammatory and antioxidant effects of sodium propionate 64
New therapeutic strategy for Parkinson's and Alzheimer's disease. 63
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 62
TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas 62
Protective effect of hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome. 61
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion 61
3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease 61
Beneficial effects of FeTSPP, a peroxynitrite decomposition catalyst, in a mouse model of spinal cord injury. 60
Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury 59
Adenosine A2A receptor selective stimulation reduces mitogen activated protein kinases in spinal cord injury: activation of jnk is reduced in oligodendrocytes 59
The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model 59
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 59
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-alpha MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE. 59
Protein Hydrolysates from Anchovy (Engraulis encrasicolus) Waste: In Vitro and In Vivo Biological Activities 59
The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease. 59
PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice 58
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation 58
The antioxidative property of melatonin against brain ischemia 57
Green Tea polyphenol extract attenuates zymosan-induced non-septic shock in mice 55
Maternal adaptation in pregnant hypertensive rats: improvement of vascular and inflammatory variables and oxidative damage in the kidney. 55
Deficiencies in Toll like receptors 4 impair the functional recovery in a mouse model of spinal cord trauma 55
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 54
Aspetti tossicologici di estratto crudo da Pelagia noctiluca (Cnidaria: Scyphozoa). 54
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice 54
Carbon dots as promising tools for cancer diagnosis and therapy 54
Stafilococchi coagulasi-negativi potenziali probiotici per il Dry Eye 54
Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice 53
Effects of combination of melatonin and dexamethasone on acute lung injury in a mice model of carrageenan-induced pleurisy 53
Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury 53
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia 53
Autophagy and Liver Diseases 53
TAK1 inhibitor enhances the therapeutic treatment for glioblastoma 53
null 53
Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma 52
Melatonin modulates signal transduction pathways and apoptosis in experimental colitis 52
BENEFICIAL EFFECTS OF ETHYL PYRUVATE IN A MOUSE MODEL OF SPINAL CORD INJURY. 52
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 52
Glycogen synthase kinase-3 beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut 51
Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma 51
Melatonin reduces hyperalgesia associated with inflammation. 51
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α. 51
Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-UM®) in Myocardial Ischaemia and Reperfusion Injury in Vivo 51
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 51
Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice 51
Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease 51
B Cell-Targeted Therapy with Anti-CD20 Monoclonal Antibody Reduced Secondary Tissue Damage and Enhanced Behavioural Recovery Following Experimental Spinal Cord Injury in Mice 51
B Cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord 51
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 51
Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study 51
Effect of ultra-micronized-palmitoylethanolamide and acetyl-l-carnitine on experimental model of inflammatory pain 51
Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma 50
Superoxide, NO, peroxynitrite and PARP in circulatory shock and inflammation. 50
KU0063794, a dual mTORC1 and mTORC2 inhibitor, reduces neural tissue damage and locomotor impairment after spinal cord injury in mice 50
PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury. 49
Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept 49
Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis 49
Au, Pd and maghemite nanofunctionalized hydroxyapatite scaffolds for bone regeneration 49
Modulation of NLRP3 inflammasome attenuated inflammatory response associated to diarrhea-predominant irritable bowel syndrome 49
A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock 48
Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha 48
Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells 48
Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice 48
Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels via astrocyte-dependent mechanisms 48
Role of Dkk-3 in the neoplastic progression of meningiomas. Could it represent a new therapeutic target? 48
Totale 6.213
Categoria #
all - tutte 65.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 6 6
2019/20201.900 164 79 6 140 16 320 244 205 60 336 295 35
2020/20212.425 199 56 575 111 257 148 87 224 324 227 93 124
2021/20222.328 23 173 55 92 117 36 181 91 75 132 470 883
2022/20236.430 533 524 288 528 465 644 95 356 2.705 46 178 68
2023/20241.533 128 271 109 156 158 404 81 101 23 99 3 0
Totale 16.065